The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Effector T Cells in Multiple Sclerosis
Open accessAbstract
Multiple sclerosis (MS) has long been considered a CD4 T-cell disease, primarily because of the findings that the strongest genetic risk for MS is the major histocompatibility complex (MHC) class II locus, and that T cells play a central role in directing the immune response. The importance that the T helper (Th)1 cytokine, interferon γ (IFN-γ), and the Th17 cytokine, interleukin (IL)-17, play in MS pathogenesis is indicated by recent clinical trial data by the enhanced presence of Th1/Th17 cells in central nervous system (CNS) tissue, cerebrospinal fluid (CSF), and blood, and by research on animal models of MS, such as experimental autoimmune encephalomyelitis (EAE). Although the majority of research on MS pathogenesis has centered on the role of effector CD4 T cells, accumulating data suggests that CD8 T cells may play a significant role in the human disease. In fact, in contrast to most animal models, the primary T cell found in the CNS in patients with MS, is the CD8 T cell. As patient-derived effector T cells are also resistant to mechanisms of dominant tolerance such as that induced by interaction with regulatory T cells (Tregs), their reduced response to regulation may also contribute to the unchecked effector T-cell activity in patients with MS. These concepts will be discussed below.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
Sallusto, F., Lenig, D., Förster, R., Lipp, M., & Lanzavecchia, A. (1999) · Nature · doi:10.1038/44385 · Cited by 5,846 · cited 2×
“CCR7− T cells can migrate into inflamed tissue and display effector functions (Sallusto et al. 1999; Bromley et al. 2005; Debes et al. 2005).”
BackgroundImmunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
Grauer, O. M., Wesseling, P., & Adema, G. J. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00315.x · Cited by 4,007
Differentiation of Effector CD4 T Cell Populations
Zhu, J., Yamane, H., & Paul, W. E. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101212 · Cited by 3,452
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Leonardi, C. L., Kimball, A. B., Papp, K. A., Yeilding, N., Guzzo, C., Wang, Y., Li, S., Dooley, L. T., & Gordon, K. B. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60725-4 · Cited by 1,874
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-500 · Cited by 1,669
Thymic selection of CD4+CD25+ regulatory T cells induced by an agonist self-peptide
Jordan, M. S., Boesteanu, A., Reed, A. J., Petrone, A. L., Holenbeck, A. E., Lerman, M. A., Naji, A., & Caton, A. J. (2001) · Nature Immunology · doi:10.1038/86302 · Cited by 1,660
Cross-presentation by dendritic cells
Joffre, O. P., Segura, E., Savina, A., & Amigorena, S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3254 · Cited by 1,637
Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo
Hickey, W. F., & Kimura, H. (1988) · Science · doi:10.1126/science.3276004 · Cited by 1,466
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Frischer, J. M., Bramow, S., Dal-Bianco, A., Lucchinetti, C. F., Rauschka, H., Schmidbauer, M., Laursen, H., Sorensen, P. S., & Lassmann, H. (2009) · Brain · doi:10.1093/brain/awp070 · Cited by 1,450
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
Steinman, L. (2007) · Nature Medicine · doi:10.1038/nm1551 · Cited by 1,376
Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187
Fate mapping of IL-17-producing T cells in inflammatory responses
Hirota, K., Duarte, J. H., Veldhoen, M., Hornsby, E., Li, Y., Cua, D. J., Ahlfors, H., Wilhelm, C., Tolaini, M., Menzel, U., et al. (2011) · Nature Immunology · doi:10.1038/ni.1993 · Cited by 1,176
El-Behi, M., Ciric, B., Dai, H., Yan, Y., Cullimore, M., Safavi, F., Zhang, G.-X., Dittel, B. N., & Rostami, A. (2011) · Nature Immunology · doi:10.1038/ni.2031 · Cited by 1,071 · cited 13×
“The secretion of GM-CSF by Th17 cells may play a fundamental role in activating CNSmyeloid cells (microglia,macrophages, and dendritic cells) as GM-CSF-deficient Th17 cells are unable to induce EAE (El-Behi et al. 2011).”
BackgroundInfluentialExacerbations of multiple sclerosis in patients treated with gamma interferon
Panitch, H., Haley, A., Hirsch, R., & Johnson, K. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92863-7 · Cited by 1,071
TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study
The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group (1999) · Neurology · doi:10.1212/wnl.53.3.457 · Cited by 1,017
Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.3.393 · Cited by 951
T cells in multiple sclerosis and experimental autoimmune encephalomyelitis
Fletcher, J. M., Lalor, S. J., Sweeney, C. M., Tubridy, N., & Mills, K. H. G. (2010) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2010.04143.x · Cited by 945
Ben‐Nun, A., Wekerle, H., & Cohen, I. R. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110307 · Cited by 916
Acute axonal injury in multiple sclerosis: Correlation with demyelination and inflammation
Bitsch, A. (2000) · Brain · doi:10.1093/brain/123.6.1174 · Cited by 898
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Helping the CD8+ T-cell response
Bevan, M. J. (2004) · Nature Reviews Immunology · doi:10.1038/nri1413 · Cited by 797
Tan, C. S., & Koralnik, I. J. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70040-5 · Cited by 776
Kuhlmann, T. (2002) · Brain · doi:10.1093/brain/awf235 · Cited by 775
Sandborn, W. J., Feagan, B. G., Fedorak, R. N., Scherl, E., Fleisher, M. R., Katz, S., Johanns, J., Blank, M., & Rutgeerts, P. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.07.014 · Cited by 753
Interleukin-17 mRNA expression in blood and CSF mononuclear cells is augmented in multiple sclerosis
Matusevicius, D., Kivisäkk, P., He, B., Kostulas, N., Özenci, V, Fredrikson, S., & Link, H. (1999) · Multiple Sclerosis Journal · doi:10.1177/135245859900500206 · Cited by 751
Panitch, H. S., Hirsch, R. L., Schindler, J., & Johnson, K. P. (1987) · Neurology · doi:10.1212/wnl.37.7.1097 · Cited by 751
Immunological decision‐making: how does the immune system decide to mount a helper T‐cell response?
Kaiko, G. E., Horvat, J. C., Beagley, K. W., & Hansbro, P. M. (2008) · Immunology · doi:10.1111/j.1365-2567.2007.02719.x · Cited by 658
OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS
Rivers, T. M., Sprunt, D. H., & Berry, G. P. (1933) · Journal of Experimental Medicine · doi:10.1084/jem.58.1.39 · Cited by 643
Preferential recruitment of interferon‐γ–expressing T H 17 cells in multiple sclerosis
Kebir, H., Ifergan, I., Alvarez, J. I., Bernard, M., Poirier, J., Arbour, N., Duquette, P., & Prat, A. (2009) · Annals of Neurology · doi:10.1002/ana.21748 · Cited by 551
TRANSFER OF ALLERGIC ENCEPHALOMYELITIS IN RATS BY MEANS OF LYMPH NODE CELLS
Paterson, P. Y. (1960) · The Journal of Experimental Medicine · doi:10.1084/jem.111.1.119 · Cited by 546
Axtell, R. C., de Jong, B. A., Boniface, K., van der Voort, L. F., Bhat, R., De Sarno, P., Naves, R., Han, M., Zhong, F., Castellanos, J. G., et al. (2010) · Nature Medicine · doi:10.1038/nm.2110 · Cited by 534
Bromley, S. K., Thomas, S. Y., & Luster, A. D. (2005) · Nature Immunology · doi:10.1038/ni1240 · Cited by 509
Cytotoxic T lymphocytes in autoimmune and degenerative CNS diseases
Neumann, H. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02154-9 · Cited by 480
The interferons and their receptors—distribution and regulation
de Weerd, N. A., & Nguyen, T. (2012) · Immunology & Cell Biology · doi:10.1038/icb.2012.9 · Cited by 480
Segal, B. M., Constantinescu, C. S., Raychaudhuri, A., Kim, L., Fidelus-Gort, R., & Kasper, L. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70173-x · Cited by 479
Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissues
Debes, G. F., Arnold, C. N., Young, A. J., Krautwald, S., Lipp, M., Hay, J. B., & Butcher, E. C. (2005) · Nature Immunology · doi:10.1038/ni1238 · Cited by 474
Role of Th1 and Th17 cells in organ-specific autoimmunity
Dardalhon, V., Korn, T., Kuchroo, V. K., & Anderson, A. C. (2008) · Journal of Autoimmunity · doi:10.1016/j.jaut.2008.04.017 · Cited by 452
T Cells Responsive to Myelin Basic Protein in Patients with Multiple Sclerosis
Allegretta, M., Nicklas, J. A., Sriram, S., & Albertini, R. J. (1990) · Science · doi:10.1126/science.1689076 · Cited by 436
ENCEPHALOMYELITIS ACCOMPANIED BY MYELIN DESTRUCTION EXPERIMENTALLY PRODUCED IN MONKEYS
Rivers, T. M., & Schwentker, F. F. (1935) · Journal of Experimental Medicine · doi:10.1084/jem.61.5.689 · Cited by 435
Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis
Brucklacher-Waldert, V., Stuerner, K., Kolster, M., Wolthausen, J., & Tolosa, E. (2009) · Brain · doi:10.1093/brain/awp289 · Cited by 431
Th1 and Th17 cells: Adversaries and collaborators
Damsker, J. M., Hansen, A. M., & Caspi, R. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05133.x · Cited by 419
Multiple Sclerosis: Current and Emerging Disease-Modifying Therapies and Treatment Strategies
Wingerchuk, D. M., & Carter, J. L. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.11.002 · Cited by 416
Human Astrocytes: Secretome Profiles of Cytokines and Chemokines
Choi, S. S., Lee, H. J., Lim, I., Satoh, J.-I., & Kim, S. U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0092325 · Cited by 408
Kabat, E. A., Wolf, A., & Bezer, A. E. (1947) · Journal of Experimental Medicine · doi:10.1084/jem.85.1.117 · Cited by 403
Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions
Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C., & Weiner, H. L. (1986) · Annals of Neurology · doi:10.1002/ana.410190610 · Cited by 399
Aloisi, F., Ria, F., & Adorini, L. (2000) · Immunology Today · doi:10.1016/s0167-5699(99)01512-1 · Cited by 392
Unraveling V(D)J Recombination
Jung, D., & Alt, F. W. (2004) · Cell · doi:10.1016/s0092-8674(04)00039-x · Cited by 378
T‐helper 17 cells expand in multiple sclerosis and are inhibited by interferon‐β
Durelli, L., Conti, L., Clerico, M., Boselli, D., Contessa, G., Ripellino, P., Ferrero, B., Eid, P., & Novelli, F. (2009) · Annals of Neurology · doi:10.1002/ana.21652 · Cited by 375
Olsson, T., Zhi, W. W., Höjeberg, B., Kostulas, V, Jiang, Y. P., Anderson, G., Ekre, H. P., & Link, H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114800 · Cited by 368
Regulatory T cells – a brief history and perspective
Sakaguchi, S., Wing, K., & Miyara, M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737593 · Cited by 362
Selection of Self-Reactive T Cells in the Thymus
Stritesky, G. L., Jameson, S. C., & Hogquist, K. A. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075035 · Cited by 328
Traugott, U., Reinherz, E. L., & Raine, C. S. (1983) · Journal of Neuroimmunology · doi:10.1016/0165-5728(83)90036-x · Cited by 315
Schneider, A., Rieck, M., Sanda, S., Pihoker, C., Greenbaum, C., & Buckner, J. H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.7350 · Cited by 301
A High-Density Screen for Linkage in Multiple Sclerosis
(2005) · The American Journal of Human Genetics · doi:10.1086/444547 · Cited by 297
Fogdell‐Hahn, A., Ligers, A., Grønning, M., Hillert, J., & Olerup, O. (2000) · Tissue Antigens · doi:10.1034/j.1399-0039.2000.550205.x · Cited by 295
HLA-DR2 Dose Effect on Susceptibility to Multiple Sclerosis and Influence on Disease Course
Barcellos, L. F., Oksenberg, J. R., Begovich, A. B., Martin, E. R., Schmidt, S., Vittinghoff, E., Goodin, D. S., Pelletier, D., Lincoln, R. R., Bucher, P., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/367781 · Cited by 293
MOLECULAR CHARACTERIZATION OF THE HUMAN INTERLEUKIN (Il)-17 RECEPTOR
Yao, Z., Spriggs, M. K., Derry, J. M. J., Strockbine, L., Park, L. S., VandenBos, T., Zappone, J., Painter, S. L., & Armitage, R. J. (1997) · Cytokine · doi:10.1006/cyto.1997.0240 · Cited by 280
The transcriptional landscape of αβ T cell differentiation
the Immunological Genome Consortium, Mingueneau, M., Kreslavsky, T., Gray, D., Heng, T., Cruse, R., Ericson, J., Bendall, S., Spitzer, M. H., Nolan, G. P., et al. (2013) · Nature Immunology · doi:10.1038/ni.2590 · Cited by 268
Isolation of myelin basic protein-reactive T-cell lines from normal human blood
Burns, J., Rosenzweig, A., Zweiman, B., & Lisak, R. P. (1983) · Cellular Immunology · doi:10.1016/0008-8749(83)90250-2 · Cited by 266
Lovett-Racke, A. E., Trotter, J. L., Lauber, J., Perrin, P. J., June, C. H., & Racke, M. K. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1528 · Cited by 260
Vaknin-Dembinsky, A., Balashov, K., & Weiner, H. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7768 · Cited by 259
Sun, J., Olsson, T., Wang, W., Xiao, B., Kostulas, V., Fredrikson, S., Ekre, H., & Link, H. (1991) · European Journal of Immunology · doi:10.1002/eji.1830210620 · Cited by 257
Oligoclonal expansion of memory CD8+ T cells in cerebrospinal fluid from multiple sclerosis patients
Jacobsen, M., Cepok, S., Quak, E., Happel, M., Gaber, R., Ziegler, A., Schock, S., Oertel, W. H., Sommer, N., & Hemmer, B. (2002) · Brain · doi:10.1093/brain/awf059 · Cited by 253
Crawford, M. P., Yan, S. X., Ortega, S. B., Mehta, R. S., Hewitt, R. E., Price, D. A., Stastny, P., Douek, D. C., Koup, R. A., Racke, M. K., et al. (2004) · Blood · doi:10.1182/blood-2003-11-4025 · Cited by 250
IFN-β Inhibits Human Th17 Cell Differentiation
Ramgolam, V. S., Sha, Y., Jin, J., Zhang, X., & Markovic-Plese, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803227 · Cited by 229
CD161highCD8+T cells bear pathogenetic potential in multiple sclerosis
Annibali, V., Ristori, G., Angelini, D. F., Serafini, B., Mechelli, R., Cannoni, S., Romano, S., Paolillo, A., Abderrahim, H., Diamantini, A., et al. (2011) · Brain · doi:10.1093/brain/awq354 · Cited by 213
Hedegaard, C. J., Krakauer, M., Bendtzen, K., Lund, H., Sellebjerg, F., & Nielsen, C. H. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02837.x · Cited by 211
HLA-A Confers an HLA-DRB1 Independent Influence on the Risk of Multiple Sclerosis
Brynedal, B., Duvefelt, K., Jonasdottir, G., Roos, I. M., Åkesson, E., Palmgren, J., & Hillert, J. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000664 · Cited by 207
Peng, H., Guerau-de-Arellano, M., Mehta, V. B., Yang, Y., Huss, D. J., Papenfuss, T. L., Lovett-Racke, A. E., & Racke, M. K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.383380 · Cited by 195
Th17 central memory T cells are reduced by FTY720 in patients with multiple sclerosis
Mehling, M., Lindberg, R., Raulf, F., Kuhle, J., Hess, C., Kappos, L., & Brinkmann, V. (2010) · Neurology · doi:10.1212/wnl.0b013e3181ebdd64 · Cited by 195
Multiple sclerosis: T-cell receptor expression in distinct brain regions
Junker, A., Ivanidze, J., Malotka, J., Eiglmeier, I., Lassmann, H., Wekerle, H., Meinl, E., Hohlfeld, R., & Dornmair, K. (2007) · Brain · doi:10.1093/brain/awm214 · Cited by 189
Multiple sclerosis: Involvement of interferons in lesion pathogenesis
Traugott, U., & Lebon, P. (1988) · Annals of Neurology · doi:10.1002/ana.410240211 · Cited by 186
A hitchhiker's guide to the nervous system: the complex journey of viruses and toxins
Salinas, S., Schiavo, G., & Kremer, E. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2395 · Cited by 185
Gross, C. C., Schulte-Mecklenbeck, A., Rünzi, A., Kuhlmann, T., Posevitz-Fejfár, A., Schwab, N., Schneider-Hohendorf, T., Herich, S., Held, K., Konjević, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1524924113 · Cited by 180
Arellano, G., Ottum, P. A., Reyes, L. I., Burgos, P. I., & Naves, R. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00492 · Cited by 174
Nielsen, N., Ødum, N., Ursø, B., Lanier, L. L., & Spee, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031959 · Cited by 172
Pathogenic CD8+ T cells in multiple sclerosis
Friese, M. A., & Fugger, L. (2009) · Annals of Neurology · doi:10.1002/ana.21744 · Cited by 171
Lawson, J. M., Tremble, J., Dayan, C., Beyan, H., Leslie, R. D. G., Peakman, M., & Tree, T. I. M. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2008.03810.x · Cited by 168
DISTRIBUTION AND QUANTITATION OF HLA-ABC AND DR (Ia) ANTIGENS ON HUMAN KIDNEY AND OTHER TISSUES
Williams, K. A., Hart, D. N. J., Fabre, J. W., & Morris, P. J. (1980) · Transplantation · doi:10.1097/00007890-198004000-00002 · Cited by 167
Ottum, P. A., Arellano, G., Reyes, L. I., Iruretagoyena, M., & Naves, R. F. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00539 · Cited by 164
Wehrens, E. J., Mijnheer, G., Duurland, C. L., Klein, M., Meerding, J., van Loosdregt, J., de Jager, W., Sawitzki, B., Coffer, P. J., Vastert, B., et al. (2011) · Blood · doi:10.1182/blood-2010-12-328187 · Cited by 164
Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides.
Tsuchida, T., Parker, K. C., Turner, R. V., McFarland, H. F., Coligan, J. E., & Biddison, W. E. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10859 · Cited by 159
Olsson, T. P. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90135-8 · Cited by 158
Schneider, A., Long, S. A., Cerosaletti, K. M., Ni, C., Samuels, P. L., Kita, M., & Buckner, J. H. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3004970 · Cited by 157
Harbo, H. F., Lie, B. A., Sawcer, S. J., Celius, E. G., Dai, K., Oturai, A. B., Hillert, J. A., Lorentzen, Å. R., Laaksonen, M., Myhr, K. M., et al. (2004) · Tissue Antigens · doi:10.1111/j.0001-2815.2004.00173.x · Cited by 149
IL-21 and IL-21 Receptor Expression in Lymphocytes and Neurons in Multiple Sclerosis Brain
Tzartos, J. S., Craner, M. J., Friese, M. A., Jakobsen, K. B., Newcombe, J., Esiri, M. M., & Fugger, L. H. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2010.10.043 · Cited by 146
Interferon-γ and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions
Traugott, U., & Lebon, P. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90130-x · Cited by 145
Increased CD8+ Cytotoxic T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
Zang, Y. C. Q., Li, S., Rivera, V. M., Hong, J., Robinson, R. R., Breitbach, W. T., Killian, J. M., & Zhang, J. Z. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5120 · Cited by 144
T Helper 1 (TH1) Functional Phenotype of Human Myelin Basic Protein-Specific T Lymphocytes
Voskuhl, R. R., Martinꝉ, R., Bergman, C., Dalal, M. A., Ruddle, N. H., & McFarland, H. F. (1993) · Autoimmunity · doi:10.3109/08916939309043888 · Cited by 139
IL-27 mediates the response to IFN-β therapy in multiple sclerosis patients by inhibiting Th17 cells
Sweeney, C. M., Lonergan, R., Basdeo, S. A., Kinsella, K., Dungan, L. S., Higgins, S. C., Kelly, P. J., Costelloe, L., Tubridy, N. J., Mills, K. H. G., et al. (2011) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2011.03.007 · Cited by 137
Interferon γ Induces Retrograde Dendritic Retraction and Inhibits Synapse Formation
Kim, I. J., Beck, H. N., Lein, P. J., & Higgins, D. M. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-11-04530.2002 · Cited by 131
Chapter 5 Emergence of the Th17 Pathway and Its Role in Host Defense
O’Quinn, D. B., Palmer, M. T., Lee, Y. K., & Weaver, C. T. (2008) · Advances in immunology · doi:10.1016/s0065-2776(08)00605-6 · Cited by 130
Montes, M., Zhang, X., Berthelot, L., Laplaud, D. A., Brouard, S., Jin, J., Rogan, S. C., Armao, D. M., Jewells, V. L., Soulillou, J., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.08.030 · Cited by 123
THE ANTIBODY RESPONSE OF RABBITS TO INJECTIONS OF EMULSIONS AND EXTRACTS OF HOMOLOGOUS BRAIN
Schwentker, F. F., & Rivers, T. M. (1934) · The Journal of Experimental Medicine · doi:10.1084/jem.60.5.559 · Cited by 122
Pelfrey, C. M., Rudick, R. A., Cotleur, A. C., Lee, J.-C., Tary‐Lehmann, M., & Lehmann, P. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1641 · Cited by 117
Regulatory T-Cell Development in the Human Thymus
Caramalho, Í., Nunes‐Cabaço, H., Foxall, R. B., & Sousa, A. E. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00395 · Cited by 116
Interleukin-22 is increased in multiple sclerosis patients and targets astrocytes
Perriard, G., Mathias, A., Enz, L., Canales, M., Schluep, M., Gentner, M., Schaeren‐Wiemers, N., & Pasquier, R. D. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0335-3 · Cited by 114
IL ‐17 and Glutamate Excitotoxicity in the Pathogenesis of Multiple Sclerosis
Kostić, M. S., Džopalić, T., Živanović, S. C., Živković, N., Cvetanović, A., Stojanović, I. R., Vojinović, S., Marjanović, G., Savic, V., & Čolić, M. J. (2014) · Scandinavian Journal of Immunology · doi:10.1111/sji.12147 · Cited by 111
Immune tolerance in multiple sclerosis
Goverman, J. M. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01016.x · Cited by 109
CD8+T cells in multiple sclerosis
Đenić, A., Wootla, B., & Rodriguez, M. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.815726 · Cited by 108
Post-thymic maturation: young T cells assert their individuality
Fink, P. J., & Hendricks, D. W. (2011) · Nature reviews. Immunology · doi:10.1038/nri3028 · Cited by 108
Isolation and characterization of CD8+ regulatory T cells in multiple sclerosis
Correale, J. D., & Villa, A. M. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.12.004 · Cited by 102
Hayashi, T., Morimoto, C., Burks, J. S., Kerr, C., & Hauser, S. L. (1988) · Annals of Neurology · doi:10.1002/ana.410240408 · Cited by 100
Immune privilege of the CNS is not the consequence of limited antigen sampling
Harris, M. G., Hulseberg, P. D., Ling, C., Kármán, J., Clarkson, B. D. S., Harding, J. S., Zhang, M., Sandor, A., Christensen, K., Nagy, A., et al. (2014) · Scientific Reports · doi:10.1038/srep04422 · Cited by 96
Regulatory T cells overturned: the effectors fight back
Walker, L. S. K. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03053.x · Cited by 91
Th22 cells are expanded in multiple sclerosis and are resistant to IFN-β
Rolla, S., Bardina, V., Mercanti, S. F. D., Quaglino, P., Palma, R. D., Gned, D., Brusa, D., Durelli, L., Novelli, F., & Clerico, M. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.5a0813-463rr · Cited by 90
Upregulation of transcription factors controlling MHC expression in multiple sclerosis lesions
Gobin, S. J. P., Montagne, L., van Zutphen, M., van der Valk, P., van den Elsen, P. J., & Groot, C. J. A. D. (2001) · Glia · doi:10.1002/glia.1096 · Cited by 84
Haufe, S., Haug, M., Schepp, C. P., Kuemmerle-Deschner, J. B., Hansmann, S., Rieber, N. P., Tzaribachev, N., Hospach, T., Maier, J., Dannecker, G. E., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30503 · Cited by 83
Kish, D. D., Li, X., & Fairchild, R. L. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802830 · Cited by 81
Baughman, E. J., Mendoza, J. P., Ortega, S. B., Ayers, C. L., Greenberg, B. M., Frohman, E. M., & Karandikar, N. J. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2010.12.003 · Cited by 81
IL-22 secreting CD4 + T cells in the patients with neuromyelitis optica and multiple sclerosis
Xu, W., Li, R., Dai, Y., Wu, A., Wang, H., Chen, C., Qiu, W., Lu, Z., Zhong, X., Shu, Y., et al. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.04.021 · Cited by 80
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Longbrake, E. E., & Racke, M. K. (2009) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.9.3.319 · Cited by 79
Elain, G., Jeanneau, K., Rutkowska, A., Mir, A. K., & Dev, K. K. (2014) · Glia · doi:10.1002/glia.22637 · Cited by 76
Ransohoff, R. M., & Estes, M. L. (1991) · Archives of Neurology · doi:10.1001/archneur.1991.00530240048017 · Cited by 74
Dressel, A., Chin, J., Sette, A., Gausling, R., Höllsberg, P., & Hafler, D. A. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4943 · Cited by 71
Oligodendroglial Response to the Immune Cytokine Interferon Gamma
Popko, B., & Baerwald, K. D. (1999) · Neurochemical Research · doi:10.1023/a:1022586726510 · Cited by 69
CSF enrichment of highly differentiated CD8+ T cells in early multiple sclerosis
Jilek, S., Schluep, M., Rossetti, A. O., Guignard, L., Goff, G. L., Pantaleo, G., & Pasquier, R. D. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.11.004 · Cited by 68
Frisullo, G., Nociti, V., Iorio, R., Patanella, A. K., Marti, A., Caggiula, M., Massimiliano Mirabella, A., Tonali, P. A., & Batocchi, A. P. (2008) · Cytokine · doi:10.1016/j.cyto.2008.08.007 · Cited by 65
IFNG polymorphisms are associated with gender differences in susceptibility to multiple sclerosis
Kantarci, O. H., Goris, A., Hebrink, D. D., Heggarty, S., Cunningham, S., Alloza, I., Atkinson, E. J., de Andrade, M., McMurray, C. T., Graham, C. A., et al. (2005) · Genes and Immunity · doi:10.1038/sj.gene.6364164 · Cited by 64
Ganor, Y., Teichberg, V. I., & Levite, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.2.683 · Cited by 63
Dettke, M., Scheidt, P., Prange, H. W., & Kirchner, H. (1997) · Journal of Clinical Immunology · doi:10.1023/a:1027374615106 · Cited by 54
Berthelot, L., Laplaud, D. A., Pettré, S., Ballet, C., Michel, L., Hillion, S., Braudeau, C., Connan, F., Lefrère, F., Wiertlewski, S., et al. (2008) · European Journal of Immunology · doi:10.1002/eji.200838023 · Cited by 52
Honma, K., Parker, K. C., Becker, K. G., McFarland, H. F., Coligan, J. E., & Biddison, W. E. (1997) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(96)00161-0 · Cited by 51
Interferon-γ Safeguards Blood-Brain Barrier during Experimental Autoimmune Encephalomyelitis
Chen, N., Wang, C., Zhang, J., Qu, L.-W., Liu, X., Lu, Y., Yang, W. C., Deng, J., Lorenz, D., Gao, P., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.019 · Cited by 51
JC virus reactivation during prolonged natalizumab monotherapy for multiple sclerosis
Chalkias, S. G., Dang, X., Bord, E., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24148 · Cited by 51
Bhela, S., Kempsell, C., Manohar, M., Dominguez‐Villar, M., Griffin, R. L., Bhatt, P. M., Kivisakk-Webb, P., Fuhlbrigge, R. C., Kupper, T. S., Weiner, H. L., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1303257 · Cited by 50
Self-citationPoulopoulou, C. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.4.2007 · Cited by 49
Janus‐like effects of type I interferon in autoimmune diseases
Axtell, R. C., & Raman, C. (2012) · Immunological Reviews · doi:10.1111/j.1600-065x.2012.01131.x · Cited by 47
Goris, A., Heggarty, S., Marrosu, M. G., Graham, C., Billiau, A., & Vandenbroeck, K. (2002) · Genes and Immunity · doi:10.1038/sj.gene.6363913 · Cited by 46
Cencioni, M. T., Santini, S., Ruocco, G., Borsellino, G., Bardi, M. D., Grasso, M. G., Ruggieri, S., Gasperini, C., Centonze, D., Barilà, D., et al. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.100 · Cited by 43
Increased HLA ‐E expression in white matter lesions in multiple sclerosis
Durrenberger, P. F., Webb, L. V., Sim, M. J. W., Nicholas, R. S., Altmann, D. M., & Boyton, R. J. (2012) · Immunology · doi:10.1111/imm.12012 · Cited by 32
MRI phenotypes based on cerebral lesions and atrophy in patients with multiple sclerosis
Tauhid, S., Neema, M., Healy, B. C., Weiner, H. L., & Bakshi, R. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.08.047 · Cited by 32
Deleterious versus protective autoimmunity in multiple sclerosis
Kostić, M. S., Stojanović, I. R., Marjanović, G., Živković, N., & Cvetanović, A. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2015.04.006 · Cited by 30
Pinschewer, D. D., Schedensack, M., Bergthaler, A., Horváth, E. J., Brück, W., Löhning, M., & Merkler, D. (2010) · Brain · doi:10.1093/brain/awq028 · Cited by 21
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
Filippi, M., Bar-Or, A., Piehl, F., Preziosa, P., Solari, A., Vukusic, S., & Rocca, M. A. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0041-4 · Cited by 1,562
Reassessing B cell contributions in multiple sclerosis
Li, R., Patterson, K. R., & Bar-Or, A. (2018) · Nature Immunology · doi:10.1038/s41590-018-0135-x · Cited by 401
Pellati, F., Borgonetti, V., Brighenti, V., Biagi, M., Benvenuti, S., & Corsi, L. (2018) · BioMed Research International · doi:10.1155/2018/1691428 · Cited by 371
The role of chemokines and chemokine receptors in multiple sclerosis
Cui, L.-Y., Chu, S.-F., & Chen, N.-H. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.106314 · Cited by 135
Jafarzadeh, A., & Nemati, M. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.09.003 · Cited by 84
Metadata
- Authors
- Kaskow, B. J., & Baecher-Allan, C.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2018-01-22
- Volume
- 8
- Issue
- 4
- Pages
- a029025
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2784734333
- Cited by
- 314
- References
- 140
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.